MENU
BNTC
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Benitec Biopharma (BNTC) Ownership - Who owns Benitec Biopharma?
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
3940 Trust Way
Phone
+1 510 780-0819
Employees
18
Web
https://www.benitec.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
354.97M
P/E Ratio
N/A
Total Cash
78.28M
Projected Growth
N/A
Total Debt
137K
Revenue
N/A
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash/Share
3.06
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
BNTC
Capitalization
355M
P/E Ratio
N/A
Risk (Beta)
0.07
Dividend Yield
N/A
Total Cash
78.3M
Total Cash/Share
3.06
Total Debt
137K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
75.9M
P/B Ratio
4.68
Cash Flow
N/A
Earnings
-0.62
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2K
Current Ratio
25.48
Current Revenue Per Employee
388.89
Dividends Per Share - Security
N/A
EBITDA
-23.8M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-42.65
Shares Held By Institutions
292M
Shares Outstanding - Current
25.5M
Total Liabilities
3.13M
Total Volume MTD
N/A
Value
-1
Gain YTD
10.016
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a biotechnology, research and development company
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
3940 Trust Way
Phone
+1 510 780-0819
Employees
18
Web
https://www.benitec.com